Chiral Separation and Enantiomeric Purity Determination of Pazufloxacin Mesilate by HPLC Using Chiral Mobile Phase Additives

Journal of Liquid Chromatography and Related Technologies

Volumn 27, Issue 5, 2004, Pages 813-827

  Zhang, Zhefeng ^a   Yang, Gengliang ^a,b   Wang, Dexian ^a   Liang, Guijian ^c   Chen, Yi ^b  

^a HEBEI UNIVERSITY   (China)

^b INSTITUTE OF CHEMISTRY   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Chiral mobile phase additives; Chiral separation phase; L phenylalanine; R and S enantiomers

Indexed keywords

ADDITIVES; CALIBRATION; CARBOXYLIC ACIDS; CORRELATION METHODS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SODIUM;

CHIRAL MOBILE PHASE ADDITIVES (CMPA); CHIRAL SEPARATION; ENANTIOMERIC PURITY DETERMINATION;

AROMATIC COMPOUNDS;

COPPER SULFATE; DRUG ADDITIVE; METHANOL; PAZUFLOXACIN; PHENYLALANINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM HYDROXIDE;

ARTICLE; CALIBRATION; CHEMICAL REACTION KINETICS; CHIRALITY; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATHEMATICAL COMPUTING; MOBILE PHASE; OPTICAL RESOLUTION; PHYSICAL PHASE; QUANTITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; SEPARATION TECHNIQUE;

EID: 1842473582     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-120029700     Document Type: Article

References (13)

1. Goodman-Gilman, A.; Goodman, L.S.; Rall, W.; Murad, F, Eds. The Pharmacological Basis of Therapeutics; MacMillan Publishing Co.: New York, NY, 1985.
2. FDA Policy Statement for the Development of New Stereoisomeric Drugs, Washington DC, May, 1992.
3. Taylor, D.R.; Maher, K. Chiral separations by high-performance liquid chromatography. J. Chromatogr. Sci. 1992, 30, 67-85.
4. Lindner, W. Recent development in HPLC enantioseparation. Chromatographia 1987, 24, 97-107.
5. Steveson, D.; Wilson, I.D. Recent Advances in Chiral Separations; Plenum Press: New York, 1990; 65.
6. Hayakawa, I.; Atarashi, S.; Yokohama, S.; Imamura, M.; Sakano, K.-I.; Furukawa, M. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother. 1986, 29, 163-164.
7. Mikamo, H.; Sato, Y.; Hayasaki, Y.; Kawazoe, K.; Tamaya, T. In vitro activities of pazufloxacin, a novel injectable quinolone, against bacteria causing infections in obstetric and gynecological patients. Chemotherapy 1999, 45, 154-157.
8. Johnson, A.P. Pazufloxacin. Curr. Opin. Anti-Invest. Drugs 2000, 1 (1), 52-57.
9. Krustulovic, A.M. Chiral Separations by HPLC; Ellis Horwood Limited: Chichester, 1989; 107.
10. Gorog, S.; Gazdag, M. Enantiomeric derivatization for biomedical chromatography. J. Chromatogr. B 1994, 659, 51-84.
11. Elisbetta, A.; Arnaldo, D.; Rosangela, M.; Roberta, V. Copper(II) complexes of diamino-diamido-type ligands as chiral eluents in the enantiomeric separation of D, L-dansylamino acids by reversed-phase high-performance liquid chromatography. J. Chromatogr. 1988, 441, 275-286.
12. Davankov, V.A.; Kurganov, A.A.; Ponomareva, T.M. J. Chromatogr. 1988, 452, 309-316.
13. Li, X.; Zeng, S. Enantiomeric resolution by chiral ligand-exchange chromatography with chiral mobile phase. Chinese J. Chromatogr. 1996, 14 (5), 354-359.